Literature DB >> 7963719

Selective expression of monocyte chemotactic and activating factor/monocyte chemoattractant protein 1 in human blood monocytes by Mycobacterium tuberculosis.

K Kasahara1, T Tobe, M Tomita, N Mukaida, S Shao-Bo, K Matsushima, T Yoshida, S Sugihara, K Kobayashi.   

Abstract

Neutrophils are the predominant leukocyte population in acute inflammation. Granulomatous inflammation such as tuberculosis is a specific type of chronic inflammation characterized by the predominant accumulation of macrophages. To clarify the mechanism of cellular recruitment in inflammation, the expression of chemokines, interleukin-8 and monocyte chemotactic and activating factor (MCAF)/monocyte chemoattractant protein 1 (MCP-1), was examined in human blood monocytes in response to lipopolysaccharide of Escherichia coli, which could induce acute inflammation, or purified protein derivative (PPD) or Mycobacterium tuberculosis, which could provoke chronic inflammation. Monocytes stimulated with PPD or M. tuberculosis expressed low levels of antigenic interleukin-8 but high levels of MCAF/MCP-1 compared with monocytes stimulated with lipopolysaccharide. Northern blot analysis showed the early induction of interleukin-8 mRNA and the delayed expression of MCAF/MCP-1 mRNA in response to PPD or M. tuberculosis. Thus, the disparate expression of chemokines may contribute to the cellular recruitment in acute and chronic inflammations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7963719     DOI: 10.1093/infdis/170.5.1238

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Trehalose 6,6'-dimycolate (cord factor) of Mycobacterium tuberculosis induces corneal angiogenesis in rats.

Authors:  N Saita; N Fujiwara; I Yano; K Soejima; K Kobayashi
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Macrophage inflammatory protein 1 alpha expression by synovial fluid neutrophils in rheumatoid arthritis.

Authors:  Y Hatano; T Kasama; H Iwabuchi; R Hanaoka; H T Takeuchi; L Jing; Y Mori; K Kobayashi; M Negishi; H Ide; M Adachi
Journal:  Ann Rheum Dis       Date:  1999-05       Impact factor: 19.103

3.  Production of monocyte chemoattractant protein 1 in tuberculosis patients.

Authors:  Y Lin; J Gong; M Zhang; W Xue; P F Barnes
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

4.  Trehalose 6,6'-dimycolate (cord factor) of Mycobacterium tuberculosis induces foreign-body- and hypersensitivity-type granulomas in mice.

Authors:  H Yamagami; T Matsumoto; N Fujiwara; T Arakawa; K Kaneda; I Yano; K Kobayashi
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

5.  Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis.

Authors:  Y Lin; M Zhang; P F Barnes
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

6.  Down-regulation of interleukin-8 secretion from Mycobacterium tuberculosis-infected monocytes by interleukin-4 and -10 but not by interleukin-13.

Authors:  C Ameixa; J S Friedland
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 7.  Innate immunity to Mycobacterium tuberculosis.

Authors:  Reinout van Crevel; Tom H M Ottenhoff; Jos W M van der Meer
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

8.  Mycobacterium bovis BCG vaccination augments interleukin-8 mRNA expression and protein production in guinea pig alveolar macrophages infected with Mycobacterium tuberculosis.

Authors:  Mark J Lyons; Teizo Yoshimura; David N McMurray
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  Regulation of interleukin-8 by interleukin-10 and transforming growth factor beta in human monocytes infected with mycobacterium bovis.

Authors:  Patricia Méndez-Samperio; Elizabeth García; Abraham Vázquez; Janet Palma
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

10.  Expression of CC and CXC chemokines and chemokine receptors in human leprosy skin lesions.

Authors:  A A Kirkaldy; A C Musonda; S Khanolkhar-Young; S Suneetha; D N J Lockwood
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.